The DOI matches its Crossref record; 106 of the 106 references it cites were found in a registry or an index.
Immune-mediated pathology in Duchenne muscular dystrophy
Open accessAbstract
Immunopathology contributes to the destruction and fibrosis of muscle in Duchenne muscular dystrophy, reducing the efficacy of dystrophin-replacement therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Shull, M. M., Ormsby, I., Kier, A. B., Pawlowski, S., Diebold, R. J., Yin, M., Allen, R., Sidman, C., Proetzel, G., Calvin, D., et al. (1992) · Nature · doi:10.1038/359693a0 · Cited by 2,985
Kulkarni, A. B., Huh, C. G., Becker, D., Geiser, A., Lyght, M., Flanders, K. C., Roberts, A. B., Sporn, M. B., Ward, J. M., & Karlsson, S. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.2.770 · Cited by 1,967
(1994) · PsycEXTRA Dataset · doi:10.1037/e546992006-001 · Cited by 1,714
Terminal Complement Inhibitor Eculizumab in Atypical Hemolytic–Uremic Syndrome
Legendre, C. M., Licht, C., Muus, P., Greenbaum, L. A., Babu, S., Bedrosian, C., Bingham, C., Cohen, D. J., Delmas, Y., Douglas, K., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1208981 · Cited by 1,586
Targeting the TGFβ signalling pathway in disease
Akhurst, R. J., & Hata, A. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3810 · Cited by 1,466
A Special Population of Regulatory T Cells Potentiates Muscle Repair
Burzyn, D., Kuswanto, W., Kolodin, D., Shadrach, J. L., Cerletti, M., Jang, Y., Sefik, E., Tan, T. G., Wagers, A. J., Benoist, C., et al. (2013) · Cell · doi:10.1016/j.cell.2013.10.054 · Cited by 1,234
Interleukin-2 and Regulatory T Cells in Graft-versus-Host Disease
Koreth, J., Matsuoka, K.-I., Kim, H. T., McDonough, S. M., Bindra, B., Alyea, E. P., Armand, P., Cutler, C., Ho, V. T., Treister, N. S., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1108188 · Cited by 1,119
The regulation of TGFβ signal transduction
Moustakas, A., & Heldin, C.-H. (2009) · Development · doi:10.1242/dev.030338 · Cited by 832
Regulatory T-Cell Responses to Low-Dose Interleukin-2 in HCV-Induced Vasculitis
Saadoun, D., Rosenzwajg, M., Joly, F., Six, A., Carrat, F., Thibault, V., Sene, D., Cacoub, P., & Klatzmann, D. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1105143 · Cited by 762
Battaglia, M., Stabilini, A., Migliavacca, B., Horejs-Hoeck, J., Kaupper, T., & Roncarolo, M.-G. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.12.8338 · Cited by 736
Mauer, J., Chaurasia, B., Goldau, J., Vogt, M. C., Ruud, J., Nguyen, K. D., Theurich, S., Hausen, A. C., Schmitz, J., Brönneke, H. S., et al. (2014) · Nature Immunology · doi:10.1038/ni.2865 · Cited by 727
The inflammasome: a danger sensing complex triggering innate immunity
Pétrilli, V., Dostert, C., Muruve, D. A., & Tschopp, J. (2007) · Current Opinion in Immunology · doi:10.1016/j.coi.2007.09.002 · Cited by 700
Cohn, R. D., van Erp, C., Habashi, J. P., Soleimani, A. A., Klein, E. C., Lisi, M. T., Gamradt, M., ap Rhys, C. M., Holm, T. M., Loeys, B. L., et al. (2007) · Nature Medicine · doi:10.1038/nm1536 · Cited by 669
Shefer, A. M., & Atkinson, W. W. (2011) · Cited by 648
Mechanism of endosomal TLR inhibition by antimalarial drugs and imidazoquinolines
Kužnik, A., Benčina, M., Švajger, U., Jeras, M., Rozman, B., & Jerala, R. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1000702 · Cited by 606
A nitric oxide synthase transgene ameliorates muscular dystrophy in mdx mice
Wehling, M., Spencer, M. J., & Tidball, J. G. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.200105110 · Cited by 530
Villalta, S. A., Nguyen, H. X., Deng, B., Gotoh, T., & Tidball, J. G. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn376 · Cited by 512
Self-citationMorris, J. C., Tan, A. R., Olencki, T. E., Shapiro, G. I., Dezube, B. J., Reiss, M., Hsu, F. J., Berzofsky, J. A., & Lawrence, D. P. (2014) · PLoS ONE · doi:10.1371/journal.pone.0090353 · Cited by 487
Expression Profiling in the Muscular Dystrophies
Chen, Y.-W., Zhao, P., Borup, R., & Hoffman, E. P. (2000) · The Journal of Cell Biology · doi:10.1083/jcb.151.6.1321 · Cited by 478
Self-citationAntifibrotic activities of pirfenidone in animal models
Schaefer, C. J., Ruhrmund, D. W., Pan, L., Seiwert, S. D., & Kossen, K. (2011) · European Respiratory Review · doi:10.1183/09059180.00001111 · Cited by 454
Transforming Growth Factor-β and the Immune Response: Implications for Anticancer Therapy
Wrzesinski, S. H., Wan, Y. Y., & Flavell, R. A. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1157 · Cited by 452
Acharyya, S., Villalta, S. A., Bakkar, N., Bupha-Intr, T., Janssen, P. M. L., Carathers, M., Li, Z.-W., Beg, A. A., Ghosh, S., Sahenk, Z., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30556 · Cited by 438
Self-citationAdvisory Committee on Immunization Practices (2017) · Pediatric Clinical Practice Guidelines & Policies · doi:10.1542/9781610020862-part06-general · Cited by 423
The role of proteases in transforming growth factor-β activation
Jenkins, G. (2008) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2007.11.026 · Cited by 360
Complexities of TGF-β Targeted Cancer Therapy
Connolly, E. C., Freimuth, J., & Akhurst, R. J. (2012) · International Journal of Biological Sciences · doi:10.7150/ijbs.4564 · Cited by 345
Gueders, M. M., Foidart, J.-M., Noel, A., & Cataldo, D. D. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.12.082 · Cited by 322
Bernasconi, P., Torchiana, E., Confalonieri, P., Brugnoni, R., Barresi, R., Mora, M., Cornelio, F., Morandi, L., & Mantegazza, R. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118101 · Cited by 297
Evolution of the mdx mouse cardiomyopathy: physiological and morphological findings
Quinlan, J. G., Hahn, H. S., Wong, B. L., Lorenz, J. N., Wenisch, A. S., & Levin, L. S. (2004) · Neuromuscular Disorders · doi:10.1016/j.nmd.2004.04.007 · Cited by 281
Vetrone, S. A., Montecino-Rodriguez, E., Kudryashova, E., Kramerova, I., Hoffman, E. P., Liu, S. D., Miceli, M. C., & Spencer, M. J. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37662 · Cited by 279
Self-citationDaly, A. C., Randall, R. A., & Hill, C. S. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01192-08 · Cited by 277
Early onset of inflammation and later involvement of TGFβ in Duchenne muscular dystrophy
Chen, Y. W., Nagaraju, K., Bakay, M., McIntyre, O., Rawat, R., Shi, R., & Hoffman, E. P. (2005) · Neurology · doi:10.1212/01.wnl.0000173836.09176.c4 · Cited by 276
Self-citationHelper (CD4+) and Cytotoxic (CD8+) T Cells Promote the Pathology of Dystrophin-Deficient Muscle
Spencer, M. J., Montecino-Rodriguez, E., Dorshkind, K., & Tidball, J. G. (2001) · Clinical Immunology · doi:10.1006/clim.2000.4966 · Cited by 268
Regulatory T cells suppress muscle inflammation and injury in muscular dystrophy
Villalta, S. A., Rosenthal, W., Martinez, L., Kaur, A., Sparwasser, T., Tidball, J. G., Margeta, M., Spencer, M. J., & Bluestone, J. A. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3009925 · Cited by 254
Self-citationAutocrine Transforming Growth Factor-β1 Promotes In Vivo Th17 Cell Differentiation
Gutcher, I., Donkor, M. K., Ma, Q., Rudensky, A. Y., Flavell, R. A., & Li, M. O. (2011) · Immunity · doi:10.1016/j.immuni.2011.03.005 · Cited by 243
Pescatori, M., Broccolini, A., Minetti, C., Bertini, E., Bruno, C., D'amico, A., Bernardini, C., Mirabella, M., Silvestri, G., Giglio, V., et al. (2007) · The FASEB Journal · doi:10.1096/fj.06-7285com · Cited by 242
LTBP4 genotype predicts age of ambulatory loss in duchenne muscular dystrophy
Flanigan, K. M., Ceco, E., Lamar, K., Kaminoh, Y., Dunn, D. M., Mendell, J. R., King, W. M., Pestronk, A., Florence, J. M., Mathews, K. D., et al. (2013) · Annals of Neurology · doi:10.1002/ana.23819 · Cited by 239
Ouyang, W., Beckett, O., Ma, Q., & Li, M. O. (2010) · Immunity · doi:10.1016/j.immuni.2010.04.012 · Cited by 236
Anti‐TNFα (Remicade®) therapy protects dystrophic skeletal muscle from necrosis
Grounds, M. D., & Torrisi, J. (2004) · The FASEB Journal · doi:10.1096/fj.03-1024com · Cited by 235
Regulatory T Cells and T Cell Depletion: Role of Immunosuppressive Drugs
Noris, M., Casiraghi, F., Todeschini, M., Cravedi, P., Cugini, D., Monteferrante, G., Aiello, S., Cassis, L., Gotti, E., Gaspari, F., et al. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006101143 · Cited by 230
(2011) · PubMed · Cited by 228
SPP1 genotype is a determinant of disease severity in Duchenne muscular dystrophy
Pegoraro, E., Hoffman, E. P., Piva, L., Gavassini, B. F., Cagnin, S., Ermani, M., Bello, L., Soraru, G., Pacchioni, B., Bonifati, M. D., et al. (2011) · Neurology · doi:10.1212/wnl.0b013e318207afeb · Cited by 217
Self-citationMerlini, L., Angelin, A., Tiepolo, T., Braghetta, P., Sabatelli, P., Zamparelli, A., Ferlini, A., Maraldi, N. M., Bonaldo, P., & Bernardi, P. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0800962105 · Cited by 208
Griggs, R. C., Moxley, R. T., Mendell, J. R., Fenichel, G. M., Brooke, M. H., Pestronk, A., Miller, J. P., Cwik, V. A., Pandya, S., Robison, J., et al. (1993) · Neurology · doi:10.1212/wnl.43.3_part_1.520 · Cited by 196
Heier, C. R., Damsker, J. M., Yu, Q., Dillingham, B. C., Huynh, T., Van der Meulen, J. H., Sali, A., Miller, B. K., Phadke, A., Scheffer, L., et al. (2013) · EMBO Molecular Medicine · doi:10.1002/emmm.201302621 · Cited by 192
Self-citationNagaraju, K., Raben, N., Merritt, G., Loeffler, L., Kirk, K., & Plotz, P. (2001) · Clinical and Experimental Immunology · doi:10.1046/j.1365-2249.1998.00664.x · Cited by 186
Self-citationInflammasome Up-Regulation and Activation in Dysferlin-Deficient Skeletal Muscle
Rawat, R., Cohen, T. V., Ampong, B., Francia, D., Henriques-Pons, A., Hoffman, E. P., & Nagaraju, K. (2010) · The American Journal of Pathology · doi:10.2353/ajpath.2010.090058 · Cited by 175
Self-citationAsynchronous remodeling is a driver of failed regeneration in Duchenne muscular dystrophy
Dadgar, S., Wang, Z., Johnston, H., Kesari, A., Nagaraju, K., Chen, Y.-W., Hill, D. A., Partridge, T. A., Giri, M., Freishtat, R. J., et al. (2014) · Journal of Cell Biology · doi:10.1083/jcb.201402079 · Cited by 174
Self-citationSildenafil reverses cardiac dysfunction in the mdx mouse model of Duchenne muscular dystrophy
Adamo, C. M., Dai, D.-F., Percival, J. M., Minami, E., Willis, M. S., Patrucco, E., Froehner, S. C., & Beavo, J. A. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1013077107 · Cited by 162
Chemokine expression and control of muscle cell migration during myogenesis
Griffin, C. A., Apponi, L. H., Long, K. K., & Pavlath, G. K. (2010) · Journal of Cell Science · doi:10.1242/jcs.066241 · Cited by 160
Villalta, S. A., Deng, B., Rinaldi, C., Wehling-Henricks, M., & Tidball, J. G. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1101267 · Cited by 158
Self-citationHagler, M. A., Hadley, T. M., Zhang, H., Mehra, K. N., Roos, C. M., Schaff, H. V., Suri, R. M., & Miller, J. D. (2013) · Cardiovascular Research · doi:10.1093/cvr/cvt083 · Cited by 154
Engel, A. G., & Biesecker, G. (1982) · Annals of Neurology · doi:10.1002/ana.410120314 · Cited by 151
Radley‐Crabb, H. G., & Grounds, M. D. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.03.016 · Cited by 149
Percival, J. M., Whitehead, N. P., Adams, M. E., Adamo, C. M., Beavo, J. A., & Froehner, S. C. (2012) · The Journal of Pathology · doi:10.1002/path.4054 · Cited by 147
Willcocks, R. J., Arpan, I., Forbes, S. C., Lott, D. J., Senesac, C., Senesac, E. S., Deol, J. K., Triplett, W. T., Baligand, C., Daniels, M. J., et al. (2014) · Neuromuscular Disorders · doi:10.1016/j.nmd.2013.12.012 · Cited by 142
Hyldahl, R. D., Nelson, B., Xin, L., Welling, T., Groscost, L., Hubal, M. J., Chipkin, S. R., Clarkson, P. M., & Parcell, A. C. (2015) · The FASEB Journal · doi:10.1096/fj.14-266668 · Cited by 135
Uaesoontrachoon, K., Yoo, H.-J., Tudor, E. M., Pike, R. N., Mackie, E. J., & Pagel, C. N. (2008) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2008.03.020 · Cited by 131
Complex and Context Dependent Regulation of Hematopoiesis by TGF‐β Superfamily Signaling
Singbrant, S., Karlsson, G., & Karlsson, S. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.04569.x · Cited by 129
A role for mast cells in the progression of Duchenne muscular dystrophy?
Gorospe, J. R. M., Tharp, M. D., Hinckley, J., Kornegay, J. N., & Hoffman, E. P. (1994) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(94)90050-7 · Cited by 128
Self-citationAndreetta, F., Bernasconi, P., Baggi, F., Ferro, P., Oliva, L., Arnoldi, E., Cornelio, F., Mantegazza, R., & Confalonieri, P. A. (2006) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2006.03.005 · Cited by 126
The Paradox of Muscle Hypertrophy in Muscular Dystrophy
Kornegay, J. N., Childers, M. K., Bogan, D. J., Bogan, J. R., Nghiem, P. P., Wang, J., Fan, Z., Howard, J. F., Schatzberg, S. J., Dow, J. L., et al. (2012) · Physical Medicine and Rehabilitation Clinics of North America · doi:10.1016/j.pmr.2011.11.014 · Cited by 126
Self-citationThrombospondin-4 Regulates Vascular Inflammation and Atherogenesis
Frolova, E. G., Pluskota, E., Krukovets, I., Burke, T., Drumm, C., Smith, J. D., Blech, L., Febbraio, M., BORNSTEIN, P. K., Plow, E. F., et al. (2010) · Circulation Research · doi:10.1161/circresaha.110.232371 · Cited by 121
Complement in the immunopathogenesis of rheumatic disease
Sturfelt, G. K., & Truedsson, L. (2012) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2012.75 · Cited by 116
Flanigan, K. M., Campbell, K., Viollet, L., Wang, W., Gomez, A. M., Walker, C. M., & Mendell, J. R. (2013) · Human Gene Therapy · doi:10.1089/hum.2013.092 · Cited by 115
Porter, J. D., Guo, W., Merriam, A. P., Khanna, S., Cheng, G., Zhou, X., Andrade, F. H., Richmonds, C., & Kaminski, H. J. (2003) · Neuromuscular Disorders · doi:10.1016/s0960-8966(02)00242-0 · Cited by 112
Farini, A., Meregalli, M., Belicchi, M., Battistelli, M., Parolini, D., D’Antona, G., Gavina, M., Ottoboni, L., Constantin, G., Bottinelli, R., et al. (2007) · The Journal of Pathology · doi:10.1002/path.2213 · Cited by 110
Choi, K., Lee, K., Ryu, S., Im, M.-J., Kook, K. H., & Choi, C. (2012) · PubMed · Cited by 110
Regeneratedmdxmouse skeletal muscle shows differential mRNA expression
Tseng, B. S., Zhao, P., Pattison, J. S., Gordon, S. E., Granchelli, J. A., Madsen, R., Folk, L. C., Hoffman, E. P., & Booth, F. W. (2002) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00202.2002 · Cited by 108
Self-citationBrzóska, E., Kowalewska, M., Markowska‐Zagrajek, A., Kowalski, K., Archacka, K., Zimowska, M., Grabowska, I., Czerwińska, A. M., Czarnecka‐Góra, M., Stremińska, W., et al. (2012) · Biology of the Cell · doi:10.1111/boc.201200022 · Cited by 106
Cai, B., Spencer, M. J., Nakamura, G. R., Tseng-Ong, L., & Tidball, J. G. (2000) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65050-x · Cited by 103
Treatment of dysferlinopathy with deflazacort: a double-blind, placebo-controlled clinical trial
Walter, M. C., Reilich, P., Thiele, S., Schessl, J., Schreiber, H., Reiners, K., Kreß, W., Müller‐Reible, C., Vorgerd, M., Urban, P. P., et al. (2013) · Orphanet Journal of Rare Diseases · doi:10.1186/1750-1172-8-26 · Cited by 100
Kissel, J. T., Burrow, K. L., Rammohan, K. W., Mendell, J. R., & the CIDD Study Group (1991) · Neurology · doi:10.1212/wnl.41.5.667 · Cited by 100
Genetic ablation of complement C3 attenuates muscle pathology in dysferlin-deficient mice
Han, R., Frett, E., Levy, J. R., Rader, E. P., Lueck, J. D., Bansal, D., Moore, S. A., Ng, R., de Bernabé, D. B.-V., Faulkner, J. A., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci42390 · Cited by 96
Lorena, D., Darby, I. A., Gadeau, A., Leen, L. L. S., Rittling, S. R., Pôrto, L. C., Rosenbaum, J., & Desmoulière, A. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2005.07.024 · Cited by 92
Dystrophin-deficient myofibers are vulnerable to mast cell granule-induced necrosis
Gorospe, J. R. M., Tharp, M. D., Demitsu, T., & Hoffman, E. P. (1994) · Neuromuscular Disorders · doi:10.1016/0960-8966(94)90068-x · Cited by 85
Self-citationBibee, K. P., Cheng, Y., Ching, J. K., Marsh, J. N., Li, A. J., Keeling, R. M., Connolly, A. M., Golumbek, P. T., Myerson, J. W., Hu, G., et al. (2014) · The FASEB Journal · doi:10.1096/fj.13-237388 · Cited by 83
Pleiotropic functions of the CXC-type chemokine CXCL14 in mammals
Hara, T., & Tanegashima, K. (2012) · The Journal of Biochemistry · doi:10.1093/jb/mvs030 · Cited by 82
Gueorguieva, I., Cleverly, A., Stauber, A. J., Pillay, N. S., Rodon, J. A., Miles, C., Yingling, J. M., & Lahn, M. M. F. (2013) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12256 · Cited by 78
Cyclosporine increases muscular force generation in Duhenne muscular dystrophy
Sharma, K. R., Mynhier, M. A., & Miller, R. G. (1993) · Neurology · doi:10.1212/wnl.43.3_part_1.527 · Cited by 75
Boppart, M. D., Burkin, D. J., & Kaufman, S. J. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.01.002 · Cited by 74
Role of toll-like receptors in the pathogenesis of dystrophin-deficient skeletal and heart muscle
Henriques‐Pons, A., Yu, Q., Rayavarapu, S., Cohen, T. V., Ampong, B., Cha, H. J., Jahnke, V. E., der Meulen, J. V., Wang, D., Jiang, W., et al. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt656 · Cited by 72
Self-citationRapamycin Ameliorates Dystrophic Phenotype in mdx Mouse Skeletal Muscle
Eghtesad, S., Jhunjhunwala, S., Little, S. R., & Clemens, P. R. (2011) · Molecular Medicine · doi:10.2119/molmed.2010.00256 · Cited by 71
Kandimalla, E. R., Bhagat, L., Wang, D., Yu, D. S., Sullivan, T., Monica, N. L., & Agrawal, S. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt078 · Cited by 71
Gussoni, E., Pavlath, G. K., Miller, R. G., Panzara, M. A., Powell, M. E. A., Blau, H. M., & Steinman, L. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.153.10.4798 · Cited by 70
An Overview of Cytokines and Cytokine Antagonists as Therapeutic Agents
Donnelly, R. P., Young, H. A., & Rosenberg, A. S. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05382.x · Cited by 70
Self-citationKirschner, J., Schessl, J., Schara, U., Reitter, B. F., Stettner, G. M., Hobbiebrunken, E., Wilichowski, E., Bernert, G., Weiss, S., Stehling, F., et al. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70196-4 · Cited by 69
Zanotti, S., Gibertini, S., Blasi, C. D., Cappelletti, C., Bernasconi, P., Mantegazza, R., Morandi, L. O., & Mora, M. (2011) · Histopathology · doi:10.1111/j.1365-2559.2011.04051.x · Cited by 66
Passerini, L., Bernasconi, P., Baggi, F., Confalonieri, P. A., Cozzi, F., Cornelio, F., & Mantegazza, R. (2002) · Neuromuscular Disorders · doi:10.1016/s0960-8966(02)00071-8 · Cited by 65
Yu, D. S., Wang, D., Zhu, F., Bhagat, L., Dai, M., Kandimalla, E. R., & Agrawal, S. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm900730r · Cited by 64
Single muscle fiber contractile properties in adults with muscular dystrophy treated with MYO‐029
Krivickas, L. S., Walsh, R. J., & Amato, A. A. (2008) · Muscle & Nerve · doi:10.1002/mus.21200 · Cited by 63
Paepe, B. D., Creus, K. K., Martin, J., & Bleecker, J. D. (2012) · Muscle & Nerve · doi:10.1002/mus.23481 · Cited by 60
Chen, X., Yang, Y.-A., Zhou, Q., Weiss, J. M., Howard, O. Z., McPherson, J. M., Wakefield, L. M., & Oppenheim, J. J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0085398 · Cited by 55
Self-citationPKC Theta Ablation Improves Healing in a Mouse Model of Muscular Dystrophy
Madaro, L., Pelle, A., Nicoletti, C., Crupi, A. N., Marrocco, V., Bossi, G., Soddu, S., & Bouché, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031515 · Cited by 54
Shi, S., de Gorter, D. J. J., Hoogaars, W. M. H., Hoen, P. A. C. ’., & ten Dijke, P. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1054-x · Cited by 53
Complement Receptor 3 Influences Toll-like Receptor 7/8-Dependent Inflammation
Reed, J. H., Jain, M. K., Lee, K., Kandimalla, E. R., Faridi, M. H., Buyon, J. P., Gupta, V., & Clancy, R. M. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.403303 · Cited by 47
Lott, D. J., Forbes, S. C., Mathur, S., Germain, S. A., Senesac, C., Sweeney, H. L., Walter, G. A., & Vandenborne, K. (2014) · Neuromuscular Disorders · doi:10.1016/j.nmd.2014.03.013 · Cited by 46
IL-6 signaling blockade increases inflammation but does not affect muscle function in the mdx mouse
Kostek, M. C., Nagaraju, K., Pistilli, E. E., Sali, A., Polo, S.-H. L., Gordon, B. S., & Chen, Y. (2012) · BMC Musculoskeletal Disorders · doi:10.1186/1471-2474-13-106 · Cited by 42
Self-citationNghiem, P. P., Hoffman, E. P., Mittal, P., Brown, K. J., Schatzberg, S. J., Ghimbovschi, S. D., Wang, Z., & Kornegay, J. N. (2013) · American Journal Of Pathology · doi:10.1016/j.ajpath.2013.07.013 · Cited by 42
Self-citationReay, D. P., Yang, M. L., Watchko, J. F., Daood, M., O’Day, T. L., Rehman, K. K., D, D. C. G., Robbins, P. D., & Clemens, P. R. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.05.008 · Cited by 41
Spastic cocontraction in hemiparesis: Effects of botulinum toxin
Vinti, M., Costantino, F., Bayle, N., Simpson, D. M., Weisz, D. J., & Graciès, J. (2012) · Muscle & Nerve · doi:10.1002/mus.23427 · Cited by 37
Cromolyn increases strength in exercised mdx mice.
Granchelli, J. A., Avosso, D. L., Hudecki, M. S., & Pollina, C. M. (1996) · PubMed · Cited by 35
Messina, S., Bitto, A., Aguennouz, M., Vita, G. L., Polito, F., Irrera, N., Altavilla, D., Marini, H., Migliorato, A., Squadrito, F., et al. (2011) · Neuromuscular Disorders · doi:10.1016/j.nmd.2011.04.014 · Cited by 33
Effects of an Immunosuppressive Treatment in the GRMD Dog Model of Duchenne Muscular Dystrophy
Barthélémy, I., Uriarte, A., Drougard, C., Unterfinger, Y., Thibaud, J. L., & Blot, S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048478 · Cited by 32
Duchenne Muscular Dystrophy Models Show Their Age
Chamberlain, J. S. (2010) · Cell · doi:10.1016/j.cell.2010.12.005 · Cited by 23
Duchenne-like myopathy in double-mutant mdx mice expressing exaggerated mast cell activity
Granchelli, J. A., Pollina, C. M., & Hudecki, M. S. (1995) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(95)00089-k · Cited by 20
Cited by
Nrf2-Keap1 signaling in oxidative and reductive stress
Bellezza, I., Giambanco, I., Minelli, A., & Donato, R. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2018.02.010 · Cited by 2,053
Duan, D., Goemans, N., Takeda, S., Mercuri, E., & Aartsma-Rus, A. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-021-00248-3 · Cited by 1,312
Panduro, M., Benoist, C., & Mathis, D. (2016) · Annual Review of Immunology · doi:10.1146/annurev-immunol-032712-095948 · Cited by 536
Lethal immunotoxicity in high-dose systemic AAV therapy
Duan, D. (2023) · Molecular Therapy · doi:10.1016/j.ymthe.2023.10.015 · Cited by 240
Moratal, C., Raffort, J., Arrighi, N., Rekima, S., Schaub, S., Dechesne, C. A., Chinetti, G., & Dani, C. (2018) · Scientific Reports · doi:10.1038/s41598-018-35429-w · Cited by 101
Metadata
- Authors
- Rosenberg, A. S., Puig, M., Nagaraju, K., Hoffman, E. P., Villalta, S. A., Rao, V. A., Wakefield, L. M., & Woodcock, J.
- Venue
- Science Translational Medicine
- Published
- 2015-08-05
- Volume
- 7
- Issue
- 299
- Pages
- 299rv4-299rv4
- ISSN
- 1946-6234 (ISSN-L)
- 1946-6242
- OpenAlex
- W2116279332
- Cited by
- 304
- References
- 106
- FWCI
- 5.40
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.